Microsatellite Instability Testing
The latest news on microsatellite instability testing.
In new guidelines, an expert panel recommended IHC and PCR for certain cancer types and pointed out knowledge gaps supporting NGS in other settings.
Promega, Henlius to Develop Microsatellite Instability CDx for Cancer Drug
The companies aim to develop the companion diagnostic for use with Henlius' investigational treatment for microsatellite instability-high solid tumors.
Biocartis Files FDA Submission for Microsatellite Instability Test in Colorectal Cancer
The assay is intended to detect
Diagnostics Firms, Lab Providers Form Genomic Profiling Coalition
The new consortium is aiming to make comprehensive genomic profiling accessible to advanced cancer patients in the US, to help inform their treatment decisions.
Promega to Develop MSI Assay as CDx for Incyte Endometrial Cancer Drug
Promega will develop its microsatellite instability assay as a companion diagnostic for Incyte's anti-PD-1 drug candidate retifanlimab in endometrial cancer.
Feb 12, 2020
Dec 17, 2019
Sep 23, 2019
Aug 8, 2019
Feb 28, 2019
Biocartis 2018 Revenues Rise 32 Percent
Jan 18, 2019
Jan 8, 2019